3rd Quarter - Report

IKARIA for IKARIA

Period 3rd Quarter 2012 Filed Oct 22, 2012 Signed by Anne E. Esposito, Vice President, Government Affairs and Public Policy

Official filing
Firm
IKARIA
Client
IKARIA
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.2227 - Medical Gas Safety Act; H.R.971 - Critical Assessment and Improvement Act of 2011; H.R.5651 - Food and Drug Administration Reform Act of 2012; S.3187 - Food and Drug Administration Safety and Innovation; and The Patient Protection and Afforable Care Act

LobbyistCovered position, as disclosed
ANNE ELIZABETH ESPOSITO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th), H.R. 2227 (112th), H.R. 5651 (112th), H.R. 971 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.